Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07453706

The Application of Sentire Surgical System Plus Patient Side Single Arm in Robotic Colorectal Surgery

Robotic assisted surgery has been performed for more than two decades with good success and safety profile. However, there was only one dominating robotic surgical system available in the past which led to high cost for robotic surgery. Recently, a new robotic surgical system (Sentire Robotic Surgical System) was introduced by researchers of The Chinese University of Hong Kong (CUHK). This new robotic surgical system aims to achieve similar outcomes and standards of robotic surgery performed using the dominating system but with a significantly lower cost. The technologic innovation and development of this new robotic system is made by the Cornerstone Robotics Limited, which is based in Hong Kong. In a pilot clinical study conducted at Prince of Wales Hospital involving 55 patients, the Sentire Surgical System C1000 had demonstrated high success rate with minimal complications in patients who underwent robotic colorectal surgery. Recently, a new component of the system - the Patient Side Single Arm, is developed. It is an independent robotic arm designed for compatibility with the Sentire Surgical System, creating the hybrid surgical system known as the C1000 Ultra. The new component may enhance port placement flexibility, minimize arm collisions with the patient or operating table, and optimize docking for seamless integration into the operating room. The Patient Side Single Arm was proven by a preclinical study using cadaveric models to be safe and effective. The investigators would therefore like to conduct a prospective clinical study to evaluate the efficacy and safety of Sentire Surgical System Plus the Patient Side Single Arm in robotic colorectal surgery. The investigators believe that the results of this study will provide data to support its use for wide range of colorectal procedures with minimal access trauma, for the benefit of patients. This system will also lead to a wider range of clinical applications for minimally invasive surgery with a cost-effective model.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adenocarcinoma or large adenoma (not amenable to endoscopic removal) located at the colorectum (from the cecum to the anal verge) amenable to minimally invasive surgery
  • Body mass index <35 kg/m2
  • Willingness to participate as demonstrated by giving informed consent

Exclusion criteria

  • T4 tumor
  • Recurrent tumor
  • Extensive previous abdominal surgery precluding minimally invasive surgery
  • Contraindication to general anesthesia
  • Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
  • Untreated active infection
  • Noncorrectable coagulopathy
  • Presence of another malignancy or distant metastasis
  • Emergency surgery
  • Vulnerable population (e.g., mentally disabled, pregnancy)

Treatment and study plan

Robotic surgery using the Sentire Surgical System Plus Patient Side Single Arm

Procedure

Robotic surgery using the Sentire Surgical System Plus Patient Side Single Arm

Primary outcomes

  1. Conversion rate

    Time frame: Up to 1 month

    The definition of a conversion for this study is an emergent or unplanned change in the treatment plan to conventional laparoscopic or open surgery.

  2. Perioperative complications

    Time frame: Up to 1 month

    Perioperative complications including intraoperative complications and all complications occurring during the hospital stay or within 30 days after discharge will be graded according to the Clavien-Dindo classification. Complications of Clavien-Dindo grade III (those requiring surgical, endoscopic, or radiologic intervention) or above are regarded as major complications.

Secondary outcomes

  1. Operative time

    Time frame: Perioperative

  2. Operative blood loss

    Time frame: Perioperative

  3. Pain scores on visual analog scale

    Time frame: Up to 1 month

    Pain scores on visual analog scale range from 0 which implies no pain at all, to 100 which implies the worst pain imaginable.

  4. Analgesic requirement

    Time frame: Up to 1 month

    Total doses of paracetamol and tramadol used postoperatively.

  5. Length of hospital stay

    Time frame: Up to 1 month

  6. Completeness of resection

    Time frame: Up to 1 month

    Completeness of total mesorectal excision (TME) is classified as complete, nearly complete, or incomplete based on gross pathologic assessment. Complete TME is defined as intact mesorectum with only minor irregularities of a smooth mesorectal surface; no defect is deeper than 5 mm; no coning toward the distal margin; and smooth circumferential resection margin (CRM) on slicing. Nearly complete TME is defined as moderate bulk to the mesorectum; irregularity of the mesorectal surface; moderate coning of the specimen; and lack of visibility of the muscularis propria visible at any site, with the exception of the insertion of the levator muscles. Incomplete TME is defined as little bulk to mesorectum with defects down onto muscularis propria and/or very irregular CRM.

  7. Resection margin positivity for malignancy

    Time frame: Up to 1 month

    A circumferential resection margin <1mm is defined as positive; a distal resection margin <1 mm is defined as positive.

  8. Number of lymph nodes harvested

    Time frame: Up to 1 month

Study contacts

Contact information is provided by the study sponsor or research team.

Kaori Futaba, MD

CONTACT

[email protected]

+852-35051495

Simon SM Ng, MD

CONTACT

[email protected]

+852-35051495

Sponsors and collaborators

Lead sponsor

Chinese University of Hong Kong

Other

Registry information

Official study title

The Application of Sentire Surgical System Plus Patient Side Single Arm in Robotic Colorectal Surgery: A Prospective Study

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 6, 2026
Registry last updated
Mar 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.